Blog · Weight Loss
Wegovy vs Ozempic is a common question in weight care, and the confusion makes sense. The two pens come from the same company and hold the same active ingredient. Below, Dr. Melanie Espinet explains how the two brands really differ, using their U.S. prescribing information: what each is labeled for, how the doses compare, what the trials showed, and how the side effects line up. If you’re weighing semaglutide against tirzepatide instead, see our semaglutide vs tirzepatide comparison. For care in Tampa Bay, start with semaglutide weight loss in Lutz.
Yes and no. Both contain semaglutide, a GLP-1 receptor agonist. It mimics GLP-1, a natural hormone that acts on the parts of the brain that regulate appetite and how much you eat. Both brands are made by Novo Nordisk, both are given as one shot under the skin once a week, and both carry the same boxed warning about thyroid C-cell tumors.
What differs is the label: the uses each brand is approved for, the doses, and the pens. Ozempic’s label is for adults with type 2 diabetes. Wegovy’s label is for long-term weight management and heart risk, at higher doses. So the honest answer to “is Wegovy the same as Ozempic?” is this: same medicine, different purposes.
| Feature | Wegovy | Ozempic |
|---|---|---|
| Active ingredient and maker | Both: semaglutide, by Novo Nordisk | |
| How it’s given | Both: one shot under the skin, once a week | |
| Main use on the U.S. label | Long-term weight management | Blood sugar control in adults with type 2 diabetes |
| Other labeled uses | Lowering the risk of heart attack, stroke and heart-related death in adults with heart disease and obesity or overweight, and treating a liver condition called MASH | Lowering heart risks in adults with type 2 diabetes and heart disease, and kidney risks in adults with type 2 diabetes and chronic kidney disease |
| Starting dose | Both: 0.25 mg once a week for the first 4 weeks | |
| Usual maintenance dose | 2.4 mg a week, with 1.7 mg as an option | 0.5, 1 or 2 mg a week, based on blood sugar |
| Highest labeled dose | 7.2 mg a week for some adults | 2 mg a week |
| Who the label covers | Adults, plus children 12 and older with obesity | Adults with type 2 diabetes |
| Boxed warning | Both: possible thyroid C-cell tumors, seen in rodents | |
Semaglutide also comes in daily tablets. The Wegovy label now includes a once-daily tablet for adults, and Novo Nordisk sells semaglutide tablets for type 2 diabetes as Rybelsus and as Ozempic tablets. Tablet and shot doses use different numbers, so their milligrams don’t line up. This guide focuses on the weekly shots.
Because both brands are the same medicine, their shot doses sit on the same milligram scale, which makes the difference easy to see. Both start at 0.25 mg once a week for four weeks and step up slowly. Both labels say the slow climb is there to lower the risk of nausea and other stomach side effects.
| Weeks | Wegovy weekly dose on the label |
|---|---|
| 1 to 4 | 0.25 mg |
| 5 to 8 | 0.5 mg |
| 9 to 12 | 1 mg |
| 13 to 16 | 1.7 mg |
| 17 and on | Maintenance: 2.4 mg recommended, or 1.7 mg |
For adults using Wegovy for weight who have handled 2.4 mg for at least four weeks and need more weight loss, the label allows a further increase to a maximum of 7.2 mg a week, sold as Wegovy HD. If a step causes trouble, the label suggests waiting four more weeks before moving up.
| Step | Ozempic weekly dose on the label |
|---|---|
| Weeks 1 to 4 | 0.25 mg |
| Week 5 on | 0.5 mg |
| If more blood sugar control is needed, after at least 4 weeks | 1 mg |
| If still more is needed, after at least 4 more weeks | 2 mg, the maximum |
So Wegovy’s usual maintenance dose, 2.4 mg, is higher than Ozempic’s highest dose, 2 mg. That is the heart of the Ozempic vs Wegovy dose question. It is also why the two aren’t swapped casually: the pens come in different strengths, and the doses were set for different goals. Only your prescriber should set or change your dose. At MeliOra, Dr. Espinet sets your dose based on how your body responds.
Wegovy is the semaglutide brand labeled for weight management, and it was studied for exactly that. In the STEP 1 trial, 1,961 adults with overweight or obesity and no diabetes took semaglutide 2.4 mg weekly or a placebo, along with lifestyle changes. After 68 weeks, people on semaglutide had lost an average of 14.9 percent of their body weight, compared with 2.4 percent on placebo.
Ozempic was studied for blood sugar, in people with type 2 diabetes, at lower doses. People still lost weight. In one 30-week trial described in its label, 388 adults with type 2 diabetes lost an average of 3.8 kg (about 8 pounds) on 0.5 mg and 4.7 kg (about 10 pounds) on 1 mg, compared with 1.2 kg (about 3 pounds) on placebo.
These numbers can’t be lined up as a fair head-to-head. The trials enrolled different people, used different doses, measured different goals and ran for different lengths of time. For weight loss in someone without diabetes, Wegovy’s label and trials are the ones that apply. Results also vary a lot from person to person, so an average is never a promise.
Semaglutide is the medicine. Ozempic is one brand name for it. Novo Nordisk sells semaglutide under several names, each with its own label: Ozempic shots and Rybelsus or Ozempic tablets for type 2 diabetes, and Wegovy shots and tablets for weight management and heart risk. When someone compares semaglutide vs Ozempic, they are comparing a medicine with one of its brands.
So a brand name alone doesn’t tell you the whole story. Whatever you’re prescribed, it’s fair to ask exactly what medicine and dose you will receive, where it comes from, and who adjusts your dose. Our guide to what changed for semaglutide pharmacies in 2026 explains why those questions matter. At MeliOra, Dr. Espinet prescribes semaglutide or tirzepatide and explains your medication at your visit.
You should not take them together. The Wegovy label says using it with other semaglutide products, or with any other GLP-1 medicine, is not recommended. Since Ozempic is semaglutide, combining them would double up on the same drug.
Moving from one to the other is your prescriber’s decision. Neither label gives a dose conversion from one brand to the other, so your doctor weighs your current dose, how long you’ve taken it, your side effects and your goals before choosing what comes next. The same care applies to any change between GLP-1 medicines, which we cover in switching from semaglutide to tirzepatide.
The side effects are the same kinds, because the medicine is the same. Ozempic’s label lists nausea, vomiting, diarrhea, stomach pain and constipation as the most common. Wegovy’s list is longer and also includes headache, fatigue, dizziness, indigestion, burping, bloating, acid reflux and hair loss. Wegovy was studied at higher doses and in different people, so the two lists are not a direct comparison.
Both labels share the same main warnings and precautions, including:
For a full rundown of what’s common, what’s rare and how to manage it, see semaglutide side effects.
Ozempic’s label covers adults with type 2 diabetes. Wegovy’s label for weight covers adults with obesity, adults with overweight plus at least one weight-related health condition, and children 12 and older with obesity. The NIH puts the usual adult threshold for weight-management medicine in numbers: a BMI of 30 or more, or 27 or more with a weight-related problem such as high blood pressure or type 2 diabetes.
A BMI number is a starting point, not the whole answer. A doctor also reviews your health history and current medicines before prescribing. Our guide on how to get a semaglutide prescription walks through who qualifies and what the visit looks like.
MeliOra Elite Wellness is a physician-led practice based in Lutz, Florida. Dr. Melanie Espinet, a board-certified family physician, evaluates, prescribes and follows every patient herself. She prescribes semaglutide or tirzepatide when it is right for you, includes lab work in your plan, and explains your medication at your visit.
At MeliOra, semaglutide is a weekly shot. It is $150/month at starting doses and $240/month for higher dosing. That monthly price includes physician visits, lab work, your medication and supplies, and dose adjustments and check-ins, with no separate consultation fee. MeliOra is a self-pay practice, and there is no travel fee anywhere in our Tampa Bay service area.
You can see Dr. Espinet through weight loss house calls across Tampa Bay, at our Lutz office for select appointments, or by telehealth visit anywhere in Florida at the same monthly price. If you’re comparing semaglutide with other medicines, our guides to Zepbound vs Wegovy and liraglutide vs semaglutide cover those questions.
This article is for education only and is not medical advice. Brand names are used only to explain what their U.S. labels say.
They contain the same medicine, semaglutide, but they are not the same product. Ozempic is labeled for type 2 diabetes, with doses up to 2 mg a week. Wegovy is labeled for weight management, with a usual maintenance dose of 2.4 mg a week. Both are made by Novo Nordisk and given once a week.
Wegovy is given at higher doses, but it is not a stronger medicine. Its usual maintenance dose is 2.4 mg a week, above Ozempic’s 2 mg maximum, and its label allows up to 7.2 mg a week for some adults. Milligram for milligram, it is the same semaglutide.
Ozempic’s U.S. label is for type 2 diabetes, not weight management. People in its diabetes trials did lose some weight. Wegovy is the semaglutide brand labeled for weight management, and the right medicine for you is a decision to make with your physician.
No. The Wegovy label says it should not be used with other semaglutide products or with any other GLP-1 medicine. Ozempic is semaglutide, so taking both would double up on the same drug.
Ozempic is one brand of semaglutide, and semaglutide is the medicine itself. Novo Nordisk also sells semaglutide as Wegovy for weight management, and as Rybelsus and Ozempic tablets for type 2 diabetes.
Mostly yes, because they are the same medicine. Nausea, diarrhea, vomiting, constipation and stomach pain are among the most common with both. Both labels share the same serious warnings, including a boxed warning about thyroid C-cell tumors.
Dr. Espinet prescribes semaglutide or tirzepatide and explains your medication at your visit. She decides whether a GLP-1 medicine is right for you after reviewing your health history and lab work. Visits happen at your home across Tampa Bay, at our Lutz office for select appointments, or by video anywhere in Florida.
Serving Lutz, Wesley Chapel, Land O'Lakes, Carrollwood, New Tampa & greater Tampa Bay.
Book Your Consultation
Free download · 15 pages
Typical units and cost by area, Botox brands Jeuveau vs. Xeomin, aftercare, a results timeline and a planner you can fill in. Free, and yours to keep.
Get the free guide
